Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Dec;34(3):864-70.
doi: 10.1128/iai.34.3.864-870.1981.

Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins

Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins

D E Van Epps et al. Infect Immun. 1981 Dec.

Abstract

Immunoglobulin A (IgA) paraproteins from patients with myeloma have been shown to inhibit human neutrophil chemotaxis to C5a, casein, and chemotactic factors produced by Escherichia coli. This study demonstrates that these paraproteins also inhibit neutrophil chemotaxis in response to the synthetic peptide formylmethionyl-leucyl-phenylalanine (f-MLP). Furthermore, the neutrophil chemiluminescence response stimulated by f-MLP was markedly suppressed by the presence of IgA paraprotein. Maximal inhibition of chemiluminescence was observed when the paraprotein was present during the chemiluminescence response. The inhibitory activity was substantially reduced by removal of the Fc region of IgA or by conversion of polymeric IgA to monomeric IgA by limited reduction and alkylation. Additional experiments showed that these IgA paraproteins inhibited C5a but not phorbol myristate acetate-stimulated chemiluminescence. These observations are constant with the hypothesis that polymeric forms of IgA bind to human neutrophils and interfere with the binding of chemotactic factor to its receptor or the consequent receptor-mediated oxidative burst or both.

PubMed Disclaimer

References

    1. J Clin Invest. 1974 Jul;54(1):122-7 - PubMed
    1. Adv Exp Med Biol. 1974;45(0):67-74 - PubMed
    1. J Biol Chem. 1975 May 25;250(10):3891-6 - PubMed
    1. Aust N Z J Med. 1975 Feb;5(1):39-43 - PubMed
    1. Proc Soc Exp Biol Med. 1975 Nov;150(2):482-4 - PubMed

Publication types

MeSH terms

LinkOut - more resources